Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Transplantation | 7 | 2025 | 572 | 2.990 |
Why?
|
| Tissue and Organ Procurement | 6 | 2024 | 254 | 1.640 |
Why?
|
| Tissue Donors | 7 | 2025 | 504 | 1.200 |
Why?
|
| Kidney Failure, Chronic | 3 | 2025 | 944 | 1.150 |
Why?
|
| Living Donors | 2 | 2025 | 118 | 1.010 |
Why?
|
| Pancreas Transplantation | 2 | 2024 | 30 | 0.940 |
Why?
|
| Glucagon-Like Peptides | 1 | 2025 | 40 | 0.910 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2025 | 76 | 0.820 |
Why?
|
| Nephrectomy | 1 | 2025 | 175 | 0.810 |
Why?
|
| Waiting Lists | 1 | 2025 | 243 | 0.800 |
Why?
|
| Organ Transplantation | 2 | 2023 | 173 | 0.770 |
Why?
|
| Weight Loss | 1 | 2025 | 530 | 0.700 |
Why?
|
| Hypoglycemic Agents | 1 | 2025 | 475 | 0.700 |
Why?
|
| Hepatitis C | 2 | 2023 | 390 | 0.690 |
Why?
|
| Renal Dialysis | 2 | 2025 | 953 | 0.670 |
Why?
|
| Anastomotic Leak | 2 | 2019 | 35 | 0.650 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2021 | 75 | 0.650 |
Why?
|
| Frailty | 1 | 2023 | 139 | 0.640 |
Why?
|
| Anastomosis, Surgical | 3 | 2019 | 175 | 0.640 |
Why?
|
| Postoperative Complications | 4 | 2025 | 3133 | 0.580 |
Why?
|
| Antiviral Agents | 3 | 2023 | 814 | 0.580 |
Why?
|
| Social Skills | 1 | 2018 | 16 | 0.570 |
Why?
|
| Surgical Stapling | 1 | 2017 | 18 | 0.510 |
Why?
|
| Gastroplasty | 1 | 2016 | 18 | 0.500 |
Why?
|
| Graft Survival | 4 | 2023 | 466 | 0.500 |
Why?
|
| Enterostomy | 1 | 2016 | 6 | 0.490 |
Why?
|
| General Surgery | 1 | 2018 | 222 | 0.470 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2016 | 51 | 0.460 |
Why?
|
| Simulation Training | 1 | 2018 | 168 | 0.460 |
Why?
|
| Colectomy | 1 | 2016 | 88 | 0.460 |
Why?
|
| Gastric Bypass | 1 | 2016 | 96 | 0.450 |
Why?
|
| Tobacco Use Disorder | 1 | 2015 | 90 | 0.440 |
Why?
|
| Liver Transplantation | 3 | 2025 | 1133 | 0.420 |
Why?
|
| Patient Care Team | 1 | 2018 | 558 | 0.420 |
Why?
|
| Communication | 1 | 2018 | 529 | 0.420 |
Why?
|
| Obesity | 1 | 2025 | 2394 | 0.410 |
Why?
|
| Obesity, Morbid | 1 | 2016 | 233 | 0.400 |
Why?
|
| Carcinoma | 1 | 2016 | 284 | 0.400 |
Why?
|
| Colonic Neoplasms | 1 | 2016 | 265 | 0.390 |
Why?
|
| Curriculum | 1 | 2018 | 786 | 0.390 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 456 | 0.360 |
Why?
|
| Stomach Neoplasms | 1 | 2016 | 580 | 0.320 |
Why?
|
| Adenocarcinoma | 1 | 2016 | 998 | 0.300 |
Why?
|
| Retrospective Studies | 10 | 2025 | 17748 | 0.290 |
Why?
|
| Aged | 7 | 2025 | 21288 | 0.280 |
Why?
|
| Humans | 23 | 2025 | 132041 | 0.280 |
Why?
|
| Operative Time | 2 | 2019 | 205 | 0.250 |
Why?
|
| Attitude of Health Personnel | 3 | 2017 | 719 | 0.250 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2025 | 78 | 0.230 |
Why?
|
| Transplant Donor Site | 1 | 2025 | 6 | 0.220 |
Why?
|
| Risk Factors | 4 | 2025 | 11020 | 0.220 |
Why?
|
| Attitude | 2 | 2023 | 112 | 0.220 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2025 | 40 | 0.220 |
Why?
|
| Middle Aged | 9 | 2025 | 28946 | 0.220 |
Why?
|
| Monitoring, Intraoperative | 1 | 2025 | 130 | 0.210 |
Why?
|
| Hepacivirus | 2 | 2023 | 273 | 0.200 |
Why?
|
| Vascular Diseases | 1 | 2025 | 155 | 0.200 |
Why?
|
| Liver | 2 | 2021 | 1805 | 0.190 |
Why?
|
| Intestines | 2 | 2017 | 592 | 0.180 |
Why?
|
| Transplantation, Homologous | 1 | 2023 | 677 | 0.170 |
Why?
|
| Kidney Diseases | 1 | 2025 | 484 | 0.160 |
Why?
|
| Brain Death | 1 | 2021 | 74 | 0.160 |
Why?
|
| Allografts | 1 | 2021 | 216 | 0.160 |
Why?
|
| Jejunostomy | 1 | 2019 | 21 | 0.160 |
Why?
|
| Graft Rejection | 1 | 2024 | 564 | 0.160 |
Why?
|
| Transplant Recipients | 1 | 2022 | 232 | 0.160 |
Why?
|
| Biliary Tract Surgical Procedures | 1 | 2019 | 23 | 0.160 |
Why?
|
| Biliary Tract Diseases | 1 | 2019 | 33 | 0.150 |
Why?
|
| Male | 10 | 2025 | 65425 | 0.150 |
Why?
|
| Kidney | 2 | 2023 | 1303 | 0.150 |
Why?
|
| Adult | 7 | 2025 | 31747 | 0.150 |
Why?
|
| Hepatitis C, Chronic | 1 | 2023 | 367 | 0.150 |
Why?
|
| Female | 10 | 2025 | 71380 | 0.140 |
Why?
|
| Intestinal Diseases | 1 | 2019 | 69 | 0.140 |
Why?
|
| Intraoperative Care | 1 | 2019 | 122 | 0.140 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2019 | 87 | 0.140 |
Why?
|
| Genetic Testing | 1 | 2025 | 1105 | 0.140 |
Why?
|
| Qualitative Research | 1 | 2022 | 708 | 0.140 |
Why?
|
| Age Factors | 1 | 2024 | 2868 | 0.140 |
Why?
|
| Blood Transfusion | 1 | 2019 | 291 | 0.130 |
Why?
|
| Surveys and Questionnaires | 4 | 2024 | 4071 | 0.120 |
Why?
|
| Follow-Up Studies | 1 | 2025 | 5287 | 0.120 |
Why?
|
| Prognosis | 1 | 2025 | 4962 | 0.120 |
Why?
|
| Policy | 1 | 2015 | 35 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2025 | 1420 | 0.110 |
Why?
|
| United States | 4 | 2025 | 11846 | 0.110 |
Why?
|
| Equipment Design | 1 | 2017 | 557 | 0.110 |
Why?
|
| Drug Costs | 1 | 2015 | 63 | 0.110 |
Why?
|
| Time Factors | 1 | 2025 | 6283 | 0.110 |
Why?
|
| Immunoglobulins | 1 | 2015 | 157 | 0.110 |
Why?
|
| Treatment Outcome | 3 | 2021 | 13025 | 0.110 |
Why?
|
| Smoking Cessation | 1 | 2015 | 190 | 0.100 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 1407 | 0.100 |
Why?
|
| Hepatitis B | 1 | 2015 | 174 | 0.100 |
Why?
|
| Pregnancy | 1 | 2025 | 7588 | 0.090 |
Why?
|
| Patient Selection | 1 | 2015 | 726 | 0.090 |
Why?
|
| Logistic Models | 1 | 2016 | 1841 | 0.090 |
Why?
|
| Databases, Factual | 1 | 2016 | 1228 | 0.080 |
Why?
|
| Smoking | 1 | 2015 | 929 | 0.080 |
Why?
|
| Health Care Surveys | 2 | 2024 | 283 | 0.080 |
Why?
|
| Diabetes Mellitus | 1 | 2017 | 894 | 0.070 |
Why?
|
| Young Adult | 2 | 2023 | 10128 | 0.060 |
Why?
|
| Hospitals, Urban | 2 | 2017 | 99 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 6930 | 0.060 |
Why?
|
| Hepatic Artery | 1 | 2025 | 47 | 0.060 |
Why?
|
| Portal Vein | 1 | 2025 | 88 | 0.050 |
Why?
|
| Whole Genome Sequencing | 1 | 2025 | 360 | 0.050 |
Why?
|
| Pancreas | 1 | 2024 | 228 | 0.050 |
Why?
|
| Preoperative Care | 1 | 2025 | 358 | 0.050 |
Why?
|
| Motivation | 1 | 2023 | 332 | 0.040 |
Why?
|
| Biopsy | 1 | 2024 | 1254 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2019 | 228 | 0.040 |
Why?
|
| Adolescent | 1 | 2017 | 21018 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2024 | 778 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2023 | 913 | 0.030 |
Why?
|
| Medical Staff, Hospital | 1 | 2017 | 94 | 0.030 |
Why?
|
| Indiana | 1 | 2016 | 6 | 0.030 |
Why?
|
| Illinois | 1 | 2016 | 17 | 0.030 |
Why?
|
| Cultural Characteristics | 1 | 2016 | 45 | 0.030 |
Why?
|
| Religion and Medicine | 1 | 2016 | 26 | 0.030 |
Why?
|
| Nursing Staff, Hospital | 1 | 2017 | 70 | 0.030 |
Why?
|
| Professional-Family Relations | 1 | 2016 | 96 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2017 | 251 | 0.030 |
Why?
|
| Trauma Centers | 1 | 2017 | 209 | 0.030 |
Why?
|
| Organophosphonates | 1 | 2015 | 21 | 0.030 |
Why?
|
| Tenofovir | 1 | 2015 | 25 | 0.030 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2015 | 59 | 0.030 |
Why?
|
| Guanine | 1 | 2015 | 65 | 0.030 |
Why?
|
| Adenine | 1 | 2015 | 123 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 545 | 0.020 |
Why?
|